BBH Holdings Information

BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 15.83%, Gilead Sciences at 12.79%, Vertex Pharmaceuticals at 10.42%, Alnylam Pharmaceuticals at 5.93%, and argenx SE at 5.63%.

Total Holdings

Top 10 Percentage

71.17%

Asset Class

Equity

ETF Category

Health

Assets

348.08M

PE Ratio

21.94

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	15.83%	182,496
2	GILD	Gilead Sciences, Inc.	12.79%	388,863
3	VRTX	Vertex Pharmaceuticals Incorporated	10.42%	76,836
4	ALNY	Alnylam Pharmaceuticals, Inc.	5.93%	49,175
5	ARGX	argenx SE	5.63%	28,374
6	REGN	Regeneron Pharmaceuticals, Inc.	5.17%	31,463
7	IQV	IQVIA Holdings Inc.	4.85%	92,449
8	INSM	Insmed Incorporated	3.74%	117,006
9	NTRA	Natera, Inc.	3.45%	88,054
10	ICLR	ICON Public Limited Company	3.37%	71,159
11	BIIB	Biogen Inc.	3.36%	88,426
12	ONC	BeOne Medicines Ltd.	3.17%	36,259
13	ILMN	Illumina, Inc.	2.88%	101,694
14	BNTX	BioNTech SE	2.85%	90,239
15	NBIX	Neurocrine Biosciences, Inc.	2.69%	73,208
16	INCY	Incyte Corporation	2.20%	97,976
17	MRNA	Moderna, Inc.	2.18%	274,799
18	TECH	Bio-Techne Corporation	1.76%	111,391
19	QGEN	Qiagen N.V.	1.68%	116,539
20	CRL	Charles River Laboratories International, Inc.	1.66%	34,424
21	BMRN	BioMarin Pharmaceutical Inc.	1.55%	89,603
22	EXAS	Exact Sciences Corporation	1.28%	95,481
23	RGEN	Repligen Corporation	1.21%	36,093
24	SRPT	Sarepta Therapeutics, Inc.	0.33%	66,961
25	n/a	Us Dollar	0.03%	115,566

As of Aug 5, 2025